Stephen M Mason insider trades: Cardinal Health (CAH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | CAH | ↓ Sell | 35,000 | $236.40 | $8.3M | Direct | Aug 20, 2026 (2d) |
| Aug 19, 2025 | CAH | ↓ Sell | 41,575 | $148.82 | $6.2M | Direct | Aug 19, 2025 (0d) |
| Aug 19, 2024 | CAH | ↓ Sell | 46,998 | $109.21 | $5.1M | Direct | Aug 19, 2024 (0d) |
| Aug 17, 2023 | CAH | ↓ Sell | 37,500 | $87.32 | $3.3M | Direct | Aug 17, 2023 (0d) |
| Nov 7, 2022 | CAH | ↓ Sell | 61,216 | $80.87 | $5.0M | Direct | Nov 9, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CAH insiders
Open-market trades in the last 12 months
About Stephen M Mason's insider trades
Stephen M Mason is CEO, GMPD Segment at Cardinal Health (CAH). Since Nov 7, 2022, Stephen has reported no open-market purchases and 5 sales worth $27.8M on SEC Form 4. In the last 12 months: 1 sale ($8.3M).
Their filings also include grants and awards (13 filings), shares withheld for taxes (8 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CAH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.